Key stats
About QIAGEN
Sector
Industry
CEO
Thierry Bernard
Website
Headquarters
Venlo
Founded
1996
ISIN
NL0012169213
FIGI
BBG006TLTGC8
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of QGEN is 41.66 CHF — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange QIAGEN stocks are traded under the ticker QGEN.
Like other stocks, QGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade QIAGEN stock right from TradingView charts — choose your broker and connect to your account.